PremiumMarket NewsWalgreens (WBA) Agrees to $300 Million Settlement over Opioid Claims Dealmakers struggle to make sense of Trump antitrust policy, WSJ says Walgreens agrees to pay over $300M to settle False Claims Act suit PremiumThe FlyMorning Movers: Stock futures rebound following days of dips Walgreens Boots Alliance reports Q2 adjusted EPS 63c, consensus 52c Walgreens Boots Alliance withdraws FY25 guidance PremiumThe FlyWalgreens’ executive chair Pessina to double stake after takeover, FT reports Loop Capital Analyst Backs Palantir (PLTR) with Buy Rating, Despite Price Target Cut Walgreen Boots put volume heavy and directionally bearish 
